Clinical Trials for Diabetes

Clinical Trials for Diabetes Yeong-Liang Lin, MD, MS Center for Drug Evaluation

Background ,[object Object],[object Object],[object Object]

Type 1 Diabetes ,[object Object],[object Object],[object Object]

Type 2 Diabetes ,[object Object],[object Object],[object Object],[object Object],[object Object]

Present treatment ,[object Object],[object Object],[object Object],[object Object],[object Object]

Clinical Trials ,[object Object],[object Object]

Consideration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Efficacy Endpoint ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

HbA1c ,[object Object],[object Object],[object Object],[object Object],[object Object]

Plasma Glucose ,[object Object],[object Object],[object Object],[object Object]

Responder Rate ,[object Object],[object Object],[object Object],[object Object]

Responder ,[object Object],[object Object]

Reduction in Insulin Dose ,[object Object],[object Object],[object Object]

Insulin Antibody ,[object Object],[object Object]

Population ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Inclusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Exclusion ,[object Object],[object Object],[object Object],[object Object]

Duration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Long Term Effectiveness ,[object Object]

Control ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Withdrawal Criteria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Concomitant Medication ,[object Object],[object Object]

Confirmatory Clinical Trials ,[object Object],[object Object],[object Object],[object Object]

Safety ,[object Object],[object Object],[object Object],[object Object],[object Object]

Insulin ,[object Object],[object Object],[object Object],[object Object],[object Object]

OHA ,[object Object],[object Object],[object Object],[object Object],[object Object]

Hypoglycemia ,[object Object],[object Object],[object Object]

Demonstration of Efficacy ,[object Object],[object Object],[object Object],[object Object]

Demonstration of Safety ,[object Object],[object Object],[object Object]

Conclusion ,[object Object],[object Object],[object Object]

Clinical Trials for Diabetes

Recommended

Recommended

More Related Content

What's hot

What's hot (17)

Similar to Clinical Trials for Diabetes

Similar to Clinical Trials for Diabetes (20)

Clinical Trials for Diabetes